SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending as investors discuss its potential following the Astria Therapeutics acquisition and upcoming FDA decision on Orladeyo for pediatric use. Community members are weighing the potential revenue from these catalysts against concerns about share dilution and overall market conditions. Some traders are eyeing specific call options, while others express frustration with the stock's historical performance relative to the biotech sector.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is trending as the community discusses its potential role in real-world asset tokenization and interoperability between blockchains, particularly highlighting its involvement in projects like the digital euro pilot and tokenized sterling deposits. Bullish sentiment is fueled by increasing institutional adoption and the limited supply of QNT, with some traders eyeing a breakout above key resistance levels. The recent buzz is around Quant's potential to revolutionize multi-chain finance and its expanding network.

**What is Jesus Coin?**  Jesus Coin was launched to transform the memecoin market with a unique narrative as the only cryptocurrency that encourages generosity.  Jesus Coin is building a native transaction network on top of Ethereum to power decentralized, charitable, applications and organizations.  **What makes your project unique?**  Jesus Coin is an ERC-20 that revolutionizes generosity through open-source smart contracts and opens the door for decentralized governance within charitable organizations.  **History of your project.** Jesus Coin was conceived by [Maker Lee](https://twitter.com/0xmakerlee), after seeing a need for innovation within the non-profit world. On April 25, 2023, $JESUS conducted a fundraising sale and was the number one trending coin on [PinkSale.finance](https://pinksale.finance/) (a presale platform.) Within 24 hours, Jesus Coin attracted over 600 holders who contributed to over $2m in trading volume on [UniSwap.](https://app.uniswap.org/#/swap?outputCurrency=0xba386a4ca26b85fd057ab1ef86e3dc7bdeb5ce70)  **What’s next for your project?**  Jesus Coin is building a decentralized app to facilitate charitable giving throughout non-profit organizations and is actively looking for new partnerships in the web2 and web3 ecosystems.  **What can your token be used for?**  Jesus Coin (JESUS) can be used as a currency and as governance within the Jesus Coin network. Because the supply of JESUS is set at 777 trillion, JESUS can also be used as a store of value.

Jesus Coin

Jesus Coin ($JESUS) is trending amid discussions around its potential and recent positive momentum, with community members drawing comparisons to other meme coins and highlighting its core concept. Conversations also incorporate religious themes and biblical references, contributing to the coin's unique online presence. The community is actively discussing potential catalysts such as exchange listings and Easter.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending following its Q3 earnings release, with community discussions focused on subscription revenue growth and AI-fueled demand; despite a clean beat, some express concern over revenue guidance and competition. The stock's price action is drawing attention, as some traders anticipate a potential bounce from oversold levels, while others highlight technical support levels and analyst rating adjustments. Community members are actively debating Workday's valuation and future growth prospects within the broader SaaS landscape.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending as analysts weigh in on its AI strategy and recent customer growth, with some highlighting its potential for expansion and others citing competition. The community is watching for a breakout above the $250 resistance, while also discussing potential pullbacks and various options trading strategies. News of partnerships and integrations are also fueling interest in the stock.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending due to community excitement surrounding its pipeline, especially VEVYE, MIEBO and TRYPTYR, which are seen as potential "game changers." Investors are actively discussing the company's upcoming Q4 report and catalysts, including a pre-NDA meeting and GLP-1 platform data, with some speculating on a future $100 stock price.

Meet Pandu — your AI friend who’s always by your side. Talk with him in real time through text or voice, share your thoughts, ask questions, or just enjoy a casual conversation. Whether you’re looking for advice, company, or simply someone to listen, Pandu is here as a true companion you can connect with anytime.  Pandu unites real-time conversation, creative generation, and future-ready AI systems — all powered by next-gen technology.

Pandu Pandas

Pandu Pandas ($PANDU) is trending as community members highlight its potential within the Solana ecosystem, citing its low market cap, growing holder base, and developing utility. The community is excited about upcoming announcements and the possibility of exchange listings, fueling discussions about its potential as the next big memecoin. Some users are comparing it to other successful memecoins on Solana.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth ($UNH) is trending as investors digest mixed sentiment around future earnings projections and ongoing regulatory scrutiny, particularly regarding OptumRx. The community is actively debating the potential impacts of ACA subsidies and a pending court case, while also weighing the stock's current valuation relative to competitors and broader market trends. Some traders are looking for a rotation into defensive stocks like UNH amid tech sector volatility.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is experiencing renewed interest, with traders eyeing key breakout levels that could signal a significant rally, while others point to a potential breach of support. The community highlights recent whale activity and a possible DeFi 2.0 narrative, suggesting institutions are accumulating COMP, but revenue and concerns about the treasury runway remain in focus.

Trump For President

Stocks and crypto associated with President Trump are seeing volatility, driving community discussion around their future. Some investors are expressing concerns about potential losses, while others are seeing the price movement as an opportunity. The community is actively discussing price predictions and the impact of broader market trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NAMS $23.68 last bid (halted) 
DAC (dollar average cost) $16.85 (8.27.24). 
NOTE: REMOVE EXIT at $27.00/MAINTAIN LEGACY HOLDING STATUS. 
NEW EXIT WILL BE DETERMINED. 
UPDATE:  
NewAmsterdam Pharma announces &quot;positive&quot; topline data from the Company’s Phase 3 TANDEM clinical trial. 
^Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each of placebo, ezetimibe 10 mg, and obicetrapib 10 mg monotherapy at day 84 with statistical significance (p&lt;0.001). 
^Obicetrapib and ezetimibe fixed-dose combination observed to lower LDL-C by approximately 50% at day 84, compared to placebo, with over 70% of patients achieving LDL-C levels below 55 mg/dL. 
^Data supports global regulatory filings of the obicetrapib 10 mg and ezetimibe 10 mg fixed-dose combination. 
^Observed to be well tolerated with safety results in line with prior studies. 
^^^ NewAmsterdam to host conference call today at 8:00 a.m. ET.

StockTwits Web

NewAmsterdam Pharma Company NV

 $23.68 last bid (halted) 
DAC (dollar average cost) $16.85 (8.27.24). 
NOTE: REMOVE EXIT at $27.00/MAINTAIN LEGACY HOLDING STATUS. 
NEW EXIT WILL BE DETERMINED. 
UPDATE:  
NewAmsterdam Pharma announces "positive" topline data from the Company’s Phase 3 TANDEM clinical trial. 
^Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each of placebo, ezetimibe 10 mg, and obicetrapib 10 mg monotherapy at day 84 with statistical significance (p<0.001). 
^Obicetrapib and ezetimibe fixed-dose combination observed to lower LDL-C by approximately 50% at day 84, compared to placebo, with over 70% of patients achieving LDL-C levels below 55 mg/dL. 
^Data supports global regulatory filings of the obicetrapib 10 mg and ezetimibe 10 mg fixed-dose combination. 
^Observed to be well tolerated with safety results in line with prior studies. 
^^^ NewAmsterdam to host conference call today at 8:00 a.m. ET.